Abstract
INTRODUCTION
The cornerstone of atrial fibrillation (AF) ablation is isolation of the pulmonary veins (PVs) [1, 2] . In patients with paroxysmal AF, success rates of catheter ablation (CA) targeting the PVs vary between 59% and 93%, off antiarrhythmic drugs (AADs) [3] . In patients with persistent AF, however, PV isolation alone is insufficient with success rates off AAD of far below 50% [4] . Even when combining PV isolation with linear lesions and/or ablation of complex fractionated atrial electrograms, CA does not exceed 41% off AAD [4] . One of the major weaknesses of endocardial CA techniques is the inability to create long-lasting linear transmural lesions [5] . This is the reason why recurrent AF after endocardial ablation is most frequently associated with PV reconnection [5, 6] . Modern surgical AF ablation techniques, on the other hand, are less affected by incomplete lesions but lack the ability to define the specific properties of the underlying atrial electrical substrate in order to customize the ablation strategy. We, therefore, developed a hybrid approach that combines a transvenous endocardial and thoracoscopic epicardial approach in a single procedure in order to overcome their mutual shortcomings [7] . In this study, we report the long-term follow-up results of this hybrid procedure.
METHODS

Study population
Sixty-four consecutive patients with symptomatic AF underwent hybrid thoracoscopic surgical and transvenous CA with follow-up of at least 3 years. Definitions of paroxysmal, persistent and longstanding persistent AF, success and failure of ablation and followup monitoring were based on the European Society of Cardiology (ESC), the European Heart Rhythm Association (EHRA) and the European Association of Cardio-Thoracic Surgery (EACTS) guidelines [1] . Patients were included if they fulfilled at least 1 of the following selection criteria: (i) previously failed CA, (ii) failure of at least 1 AAD, (iii) left atrial (LA) volume > _29 ml/m 2 , (iv) persistent or long-standing persistent AF and (v) patient preference for a hybrid procedure instead of a percutaneous approach. Eighteen (32%) patients had prior CA for AF and 11 (20%) for atrial flutter (AFL). The preoperative workup consisted of transthoracic echocardiography, †The first two authors contributed equally to this study. cardiac computed tomography or coronary angiography and pulmonary function testing.
Hybrid procedure
The hybrid ablation procedure was performed as described in detail elsewhere [7] . Briefly, 2 working ports and 1 camera port were inserted on both sides of the thorax. Via a femoral venous approach, a His bundle (St. Jude Medical, St Paul, MN, USA) and coronary sinus (CS) catheter (Medtronic, Minneapolis, MN, USA) were placed under fluoroscopy, and trans-septal puncture was performed into the left atrium, followed by heparinization. Antral isolation of the right and left PVs as a pair was performed with a bipolar radiofrequency (RF) clamp (AtriCure, West Chester, OH, USA). In order to avoid bilateral sequential lung deflation in patients with severe chronic obstructive pulmonary disease, we performed thoracoscopic epicardial isolation of the PVs only on the right, and the left PVs were isolated endocardially using a 28-mm cryothermal energy balloon catheter (Arctic Front; CryoCath, Montreal, QC, Canada). In the case of normal sinus rhythm (NSR) after PV isolation, reinduction of AF was attempted by burst pacing in the CS. If AF became non-inducible, isoproterenol was infused at rates of 10-30 lg/min. If AF had not terminated or was still inducible, linear lesions were created. A roof line and an inferior line were made epicardially using a bipolar RF pen or linear pen device (Isolater Pen and Coolrail; AtriCure). These 2 linear lesions, in combination with bilateral antral PV isolation, result in electrical isolation of the posterior LA (box lesion). Any conduction gap in these epicardial linear lesions was ablated endocardially with a 3.5-mmtip catheter (Thermo-Cool; Biosense Webster). A left isthmus line was made epicardially using the bipolar RF pen device in patients developing a mitral isthmus-dependent left AFL during the procedure. All patients needed endocardial touch-up ablation of the mitral isthmus line to reach bidirectional block. If the patient was known to have typical AFL or if this arrhythmia occurred during the procedure, the cavotricuspid isthmus (CTI) was ablated endocardially. If the right atrium was dilated on transthoracic echocardiography, 2 additional epicardial ablation lines were performed with the bipolar clamp (AtriCure): one encircling the superior caval vein and the other connecting both caval veins. Patients still in AF after PV isolation and deployment of linear lesions underwent ablation of complex atrial fragmented electrograms (CFAEs) and, if necessary, electrical cardioversion. The left atrial appendage (LAA) was addressed in patients with a CHA 2 DS 2 -VASc score > _1 and when deemed safe. Six hours after the procedure, low-molecularweight heparin was started. Warfarin was reinitiated on the 2nd postoperative day and the preoperative AAD regimen as soon as possible. If the 6-month monitoring visit confirmed the absence of atrial arrhythmia, warfarin and AADs were stopped.
Long-term follow-up
Any symptomatic patient not in NSR was cardioverted before the 3-month follow-up visit. Two patients had a previous pacemaker implantation which was used for atrial arrhythmia monitoring. The remaining patients underwent 7-day continuous Holter monitoring at 3, 6, 9, 12, 24 and 36 months. If 7-day Holter monitoring was not available, patients underwent at least 24-h Holter monitoring. According to current guidelines, success was defined as no episode of AF, AFL or any atrial tachycardia (AT) lasting more than 30 s off AAD after the 3-month blanking period [1] . Thirteen (20%) patients developed recurrent supraventricular arrhythmia. They were offered the options of AAD or an invasive electrophysiology study.
Statistical analysis
Data were retrospectively entered into a database. Statistical analysis was performed using SPSS version 20.0 (SPSS, Inc., Chicago, IL, USA). Continuous variables are summarized with means and standard deviations or as median and interquartile range. Outcomes are displayed using Kaplan-Meier plots. Any episode of AF, AFL or AT lasting more than 30 s detected after the 3-month post-procedural period by electrocardiography, pacemaker interrogation or 7-day, 48-h or 24-h continuous Holter monitoring performed at 6, 9, 12, 24 and 36 months was considered a failure.
RESULTS
Perioperative results
Sixty-four consecutive patients underwent the hybrid procedure between 29 May 2008 and 16 April 2012. No patients were excluded because of enrolment in a specific trial. One-year followup of the first 26 patients of this series was reported previously [7] . Baseline characteristics of patients are presented in Table 1 . Thirty patients had persistent AF, and 4 patients had long-standing persistent AF. Twenty-two patients had at least 1 previous CA for AF aimed at isolating all PVs, but in only 2 patients all the PVs appeared to be isolated. No patient had undergone previous cardiothoracic surgery. Twenty-six (41%) patients were in AF at the start of the procedure. The mean follow-up period was 1732 ± 353 days (range 1084-2481 days). There were 2 patients with tricuspid valve regurgitation grade 2/4 and 6 patients with mitral valve regurgitation 2/4. In all patients, block of all the PVs was achieved (Fig. 1) . As discussed before, the PVs were still isolated after previous CA in 2 patients. In 54 patients, bilateral epicardial PV isolation was performed. In 7 patients with severe chronic obstructive pulmonary disease, we performed thoracoscopic epicardial isolation of the right PVs while the left PVs were isolated endocardially using a 28-mm cryothermal energy balloon catheter (Arctic Front; CryoCath). In a 79-year-old patient with tachycardiomyopathy, only thoracoscopic epicardial isolation of the left PVs was performed, while the right PVs were isolated endocardially using a 28-mm cryothermal energy balloon catheter. In all 11 patients with 'preoperative' AFL ablation, we were able to demonstrate bidirectional block over the CTI. In 9 patients, AF was not inducible anymore after PV isolation only. In 2 of them, we performed ablation of the CTI because of previously documented typical AFL. In 3 patients, a CTI-dependent counterclockwise right AFL was induced after PV isolation and successfully ablated. In 1 of these 3 patients, we were able to reinduce AF. We deployed an epicardial roof line in 53 patients. This resulted in conversion to NSR in 6 patients. In 3 of them, it was possible to reinduce AF. In 50 patients, a box lesion was created epicardially by deploying an inferior line. In 7 patients, this resulted in a mitral isthmus-dependent AFL. In all of these 7 patients, we obtained NSR by ablation at the mitral isthmus. In all cases, the mitral isthmus line had to be completed from the endocardium or within the CS. Twenty-seven patients converted to NSR after creation of the box lesion and in 4 of them additional ablation at the CTI was performed (1 patient with inducible right AFL and 3 patients known with right AFL). Four patients converted to right AFL after creation of the box lesion. After endocardial touch-up in 10 (20%) of the 50 patients with a box lesion, we were able to demonstrate endocardial entrance and exit block in the box during NSR. In 6 of these 10 patients, there was a gap in the roof line at the junction of the right superior PV with the roof of the LA. Two patients had a gap in the lateral portion of the roof line (at the junction of the LA roof with the left superior PV) and 1 patient in the middle of the inferior line. One patient had a gap at the antrum of the right inferior PV. Twelve patients were still in AF after creation of the box lesion. After CFAE ablation, 6 patients converted to NSR. In 1 patient, we deployed an epicardial left fibrous trigone linear lesion, but AF remained. In 6 patients, electrical cardioversion was performed. In 20 patients, an epicardial intercaval line was created in combination with isolation of the superior caval vein. Fourteen (22%) patients were discharged on amiodarone and 60 (94%) on warfarin. All patients left the hospital in NSR.
Management of the left atrial appendage
The LAA was addressed in 23 (36%) patients. In February 2011, the AtriClip device was introduced into our practice. Prior to this date, 10 of the 46 patients underwent LAA exclusion using a stapling device (22%, but 1 patient was lost to follow-up). After the introduction of the AtriClip, 13 of the 17 (76%) patients underwent LAA occlusion. This difference in LAA management is due to the fact that stapling of the LAA is more challenging and was applied only if deemed to be safe. In patients with a right thoracoscopic approach only, the LAA was not addressed.
Long-term follow-up
Sixty-three (98%) patients reached 3-year follow-up, and 1 (2%) patient was lost to follow-up (Fig. 2) . No transient ischaemic attacks or strokes during follow-up were observed.
In paroxysmal AF patients, arrhythmia-free cumulative survival rates after 1 hybrid AF ablation procedure without Class I or III AAD drugs and without redo CA were 83%, 80% and 80% after 1, 2 and 3 years, respectively (Fig. 3A) . In (long-standing) persistent AF patients, these were 82%, 79% and 79% after 1, 2 and 3 years (Fig. 3B) . This resulted in an overall 3-year freedom from AF/AT/ AFL off after 1 hybrid procedure of 80% in paroxysmal AF (24 of 30 patients) and 79% in non-paroxysmal AF (26 of 33 patients).
When evaluating patients at 3 years, 60 of 63 (95%) patients were in NSR [97% (29 of 30 patients) of the paroxysmal AF group, 94% (31 of 33 patients) of the non-paroxysmal AF group], with no episodes of AF, AFL or AT lasting longer than 30 s on office follow-up, Holter monitoring or pacemaker interrogation. These results are not cumulative and include patients on AAD and/or redo CA after the initial blanking period. Six (9%) of these 63 patients were on AAD. All 6 patients on AAD were in sinus rhythm at the 3-year follow-up point. Of the 63 patients, 19 (36%) were on warfarin. Thirteen (20%) patients experienced at least 1 recurrent episode of AF, AFL or AT lasting longer than 30 s (Table 2) during follow-up.
A total of 10 (16%) patients underwent CA for recurrence of supraventricular arrhythmia after the hybrid procedure. The most common recurrent arrhythmias were AF (7 patients) and left AFL (5 patients). In this group of 10 patients who underwent CA for supraventricular tachycardia (SVT) recurrence after hybrid ablation, only 5 (12%) of 40 mapped PVs showed reconnection.
Complications
No deaths or conversion to cardiopulmonary bypass were encountered during hybrid AF ablation. No patient suffered from paralysis of the phrenic nerve. No pacemaker was implanted after the hybrid procedure. One patient had a pleural effusion that was drained 3 weeks after surgery. One patient had a minithoracotomy because of haemothorax, but no active bleeding was found. One patient stayed hospitalized for 13 days because of difficulty controlling chest pain at the insertion sites of the working ports, without signs of infection. One patient developed adult respiratory stress syndrome and was successfully treated with steroids and antibiotics.
DISCUSSION
Main findings
This is the first report on the long-term follow-up of hybrid thoracoscopic surgical and transvenous CA for AF. Sixty-three patients were followed up during 3 years. Thirteen patients had a recurrence of arrhythmia, which was treated with CA or AADs. According to accepted definitions, our overall 3-year freedom from arrhythmia without AADs or redo CA was 80%. Of note, arrhythmia outcome did not differ between patients presenting with paroxysmal and persistent AF.
Long-term follow-up
Until recently, studies reporting outcomes of AF ablation had mostly limited follow-up of 1-2 years after the first ablation procedure [1, 8, 9] . Weerasooriya et al. [10] reported 63% freedom from recurrent AF after percutaneous CA by 5 years of follow-up, with repeat interventions in 51% of patients. In that study, 63% of patients had paroxysmal AF. Results from the Hamburg group were comparable: 47% of paroxysmal AF patients remained in NSR after the initial procedure during a median follow-up period of 4.8 years [11] . The same group published recently their longterm follow-up after ablation of long-standing persistent AF: during a 5-year follow-up, single-and multiple ablation procedure success was 20% and 45%, respectively [12] . Teunissen et al. [13] reported total success rates of 41% after 1 CA procedure and 63% allowing multiple procedures after a mean follow-up of 4.5 years. Also here, outcomes after multiple procedures were better for patients with paroxysmal AF than patients with persistent or long-standing persistent AF (72%, 50.0% and 41%, respectively) [13] . Surgical AF ablation, on the other hand, results in improved long-term outcome. Prasad et al. [14] reported a success rate of up to 97% at a median follow-up of 5.4 ± 2.9 years after Cox Maze III procedure. However, one of the major criticisms was that success rate was based mostly on telephone interviews and electrocardiogram (ECG) strips, and very seldom on 24 h or longer Holter monitoring [15] . Lawrance et al. [16] reported a 77% (82% with AAD) success rate with the Cox Maze IV procedure after 2 years using mostly Holter monitoring or at least an ECG. An obvious drawback of the Cox Maze III/IV procedure is its invasiveness, the need for cardiopulmonary bypass and its surgical complexity. Recently, 5-year results on stand-alone minimal invasive Cox Maze III/IV for patients with non-paroxysmal AF were reported [17] . At 5 years, 73% off patients were in NSR after 1 procedure off AAD with the far majority of patients followed using Holter registration. In patients with paroxysmal AF who underwent off-pump bilateral PV isolation using a bipolar clamp through minithoracotomy or solely thoracoscopy, De Maat et al. [18] reported success rates of 69% (83% with AAD) after a mean follow-up of 5 years. In this study, 79% of LAAs were excluded (AtriClip device) [18] . In our series of patients with long-term follow-up after hybrid AF ablation, we demonstrated an overall success rate (freedom of any AF/AFL/AT episode longer than 30 s off AAD and without redo CA) of 80% at 3 years. First of all, the results are substantially similar between patients with paroxysmal and non-paroxysmal AF. To classify these patients, we solely relied on the classification as provided by the referring physician. However, a substantial number of the so-called 'paroxysmal AF' patients were actually non-self-terminating and were cardioverted after <7 days. Looking at the degree of LA dilatation and the complexity of the AF pattern on the surface ECG in these paroxysmal AF patients, we believe a substantial number of these patients were already in an advanced disease stage (structural and electrical remodelling). Furthermore, the results reflect the complementarity of both techniques. Indeed, in 20% of the patients, endocardial touch-up was necessary to complete the box lesion. There are 2 important points of attention when creating linear lesions from the epicardium. The first is the presence of epicardial adipose tissue. This tissue acts as an isolator and makes it difficult to create completely transmural lesions. The second point is the use of bipolar but uniparietal RF energy to create linear lesions from the epicardium. It is, therefore, of great importance to check the bidirectional block across these linear lesions from the endocardium, especially because incomplete transmural lesions can lead to iatrogenic AFLs or AT. The unique combination of epicardial surgical ablation lesions with endocardial mapping and touch-up abilities seems to result in a more long-lasting aspect of the lesion set. Moreover, the stepwise approach that was followed in this patient population clearly demonstrates that most of the patients require more than PV isolation alone. As a consequence of the stepwise approach, the surgical lesion set differed throughout the study, but this reflects the true nature of a 'hybrid' approach. Finally, when allowing redo CA and the use of AAD, 95% of all patients were in sinus rhythm at the 3-year time point of followup. As mentioned before, 6 of these patients in sinus rhythm were on AAD. These results are in line with the recent report of Duytschaever et al. [19] , who demonstrated reduced arrhythmia recurrence after CA when continuing previously ineffective AAD.
Recurrent arrhythmias
The incidence of recurrent ATs after endocardial ablation of persistent AF has been reported to be as high as to 40% [20] . Rostock et al. [21] analysed a total number of 133 ATs that occurred after stepwise ablation in 61 patients with persistent AF. The redo procedure was performed at a mean of 7.7 ± 4.4 months after the initial ablation. The arrhythmia mechanism was based on re-entry in 72% and 28% were focal ATs. Roof and perimitral flutter (43% and 34%, respectively) were the most common reentrant circuits. Focal ATs mainly originated from PVs (41%) and CS (23%). They also found that 74% of patients had conduction recovery of at least 1 PV. Almost all these ATs (93%) could be successfully ablated. Kron et al. [22] reported recurrent AT in 40% of patients after minimally invasive thoracoscopic surgical PV isolation with bipolar RF and ganglionated plexi (GP) ablation during a minimal follow-up of 12 months. In patients who underwent electrophysiology study, the most common arrhythmias were AF and AFL. In patients with recurrent AF, PV reconnection was the predominant finding: of the 44 PVs examined, 22 (50%) reconnected. Four AFLs were seen: 2 were CTI dependent, 1 was located at the posterior right atrium and the mechanism of 1 left AFL could not be determined. Only 1 patient had a focal AT in the left septum. In our series of 64 patients undergoing hybrid AF ablation, we report an arrhythmia recurrence rate of only 20% after a followup of up to 3 years. The most frequently occurring recurrent arrhythmias were left AFL and AF. Left AFL occurred in 5 patients, and in 1 of them the re-entry circuit was the result of an incomplete linear lesion. In the remaining 4 patients with left AFL, the circuit appeared to be unrelated to the lesion set deployed during hybrid AF ablation. In the 7 patients with recurrent AF, 2 showed reconnection of PVs: 1 patient had reconnection of both left PVs and the right superior PV, and 1 patient had reconnection of both right PVs. In the latter patient, the bipolar RF clamp used during hybrid AF ablation to isolate the right PVs 'en bloc', appeared to be too short for that patient's anatomy. It was not possible to position the upper part of the antrum (junction of the right superior PV with the LA roof) between the 2 jaws of the clamp. RF application with the clamp resulted in acute isolation of both right PVs, but subsequent recovery of conduction at that spot led to reconnection. In order to avoid this phenomenon in the future, we changed our approach and always perform an endocardial touch-up whenever the bipolar clamp does not completely encompass the antrum of ipsilateral PVs.
PV reconnection after the initial PV isolation remains the most important reason for AF recurrence [1, 2] . It is present in more than 80% of patients who undergo a repeat procedure [6, 23, 24] . In patients with paroxysmal AF undergoing percutaneous PV isolation, Kuck et al. [5] found a PV reconnection rate as high as 70% after 3 months while all PVs were isolated at the index ablation procedure. In this study, PV reconnection resulted in higher AF recurrence rates. The use of a bipolar RF clamp with bilateral clamping of the PVs as in our study seems to result in permanent transmurality in almost all of our cases [25, 26] . Velagic et al. [27] performed repeat CA in 14 patients after hybrid AF ablation and found that only 9% of PVs had reconnected. It remains unclear, however, why Kron et al. [22] , while using the same device to perform PV isolation, reported 50% PV reconnection. In our series this was the case in only 12% of the tested PVs. A possible explanation for this intriguing finding could be the difference in the number of RF applications. Kron et al. performed 1-5 (mean 3) additional bonus lesions after the first RF application. In our series, we performed at least 6 RF applications per PV antrum in order to avoid incomplete lesions. The reason to perform this relatively high minimum number of applications is the fact that the length of each application is dictated by the bipolar RF generator itself. The generator automatically terminates RF energy (maximum 28 W) after a prespecified impedance change that is believed to indicate transmural injury. However, the presence of epicardial fat and thicker atrial tissue may influence these impedance changes and hence lead to the wrong conclusion that a specific impedance change is indicative of complete transmurality.
Limitations
The small number of patients and the non-randomized nature of this single-centre observational study prevent definitive conclusions. To date randomized controlled trials comparing standard CA to simultaneous or sequential hybrid approaches are lacking.
The present study cannot answer whether a simultaneous endo-and epicardial procedure is better than a sequential hybrid procedure with surgery first and endocardial approach later. The latter procedure is less complex and may yield less complications but lacks the advantages of immediate check of completeness of surgical lesions and the impact of the immediate touch-up ablations which add up with the fresh surgical lesion, thereby enhancing transmurality of lesions. Although only 2 patients had isolated PVs after previous CA, we cannot exclude the fact that previous CA may have favourably influenced the results. In the present series, the overall clinical success may have been overestimated because some episodes of asymptomatic arrhythmia may not have been detected by the relatively short periods of ambulatory monitoring. An ablation strategy based on non-inducibility could lead to overtreatment of some patients. The fact that the success rate in patients with persistent AF was not significantly lower than in those with paroxysmal AF may be explained by the relatively low number of included patients, but it may also reflect the effectiveness of this approach. In this study, CFAE ablation was still performed because results of the STAR-AF II trial came out only in 2015 [4] . Since then, we have stopped using CFAE ablation.
CONCLUSIONS
A combined hybrid thoracoscopic surgical and transvenous CA procedure for AF has a 3-year success of 80% for patients with paroxysmal AF and 79% for patients with non-paroxysmal AF. Bipolar, bilateral RF clamp ablation seems to be very effective in producing definitive PV isolation and may appear useful in patients in whom a one-time procedure is preferred over the prospect of repeated percutaneous CA procedures. Recurrent supraventricular arrhythmias after a hybrid AF ablation procedure can be treated with CA or AADs.
